Sep 13,2021

Digital therapeutics provide cancer patients with information, training instructions and behaviour advices

So far there are two DiGAs for cancer patients: Mika and Pro-React Onco . Both are only provisionally approved, further evidence of the benefit for patients is to be presented. The Mika app is used to support the alleviation of psychological and psychosomatic consequences of cancer diagnoses and therapies. Cankado's Pro-React Onco is a web and app-based digital health application designed to support breast cancer patients over the age of 18. “Pro-React Onco supports breast cancer patients under systemic, antitumor or antihormonal therapy in adjuvant, neoadjuvant, post-neoadjuvant or palliative situations,” writes the BfArM in the approval declaration.

#mobile app

View Analyst & Ambassador Comments
Go to original news
Sep 23,2021

Carevive Introduces Carevive SMART Data™ to Highlight the Real-World Oncology Patient Experience

Carevive Systems (Carevive), the leading oncology-focused health technology company centered on understanding and improving the experience of patients with cancer, today launched Carevive SMART Data™, a dataset containing information from patients about their experience with treatment, combined with demographic and clinical data. Carevive SMART Data™ are captured as part of Carevive OPT-IN®. Carevive OPT-IN®, the Oncology Pragmatic Trial Investigator Network, enables patient experience data to be collected from real-world patients who are receiving treatment for cancer.

PRODUCT

#rwd

#platform

View Analyst & Ambassador Comments
Go to original news
Sep 01,2021

Belong.Life Launches i-Belong High-Engagement Platform

Belong.Life, a developer of global patient engagement and research platforms, and the largest health networks for cancer, multiple sclerosis and other diseases, announced today the launch of i-Belong – Connecting Communities. i-Belong is a self-managed platform for health ecosystem players to build customizable communities and social networks. i-Belong will offer payers, providers, pharmaceuticals and patient advocacy groups personalized and configurable engagement tools to enable organizations to serve more patients effectively and efficiently.

PRODUCT

#platform

View Analyst & Ambassador Comments
Go to original news
Sep 21,2021

FDA Authorizes Software that Can Help Identify Prostate Cancer

Today, the U.S. Food and Drug Administration authorized marketing of software to assist medical professionals who examine body tissues (pathologists) in the detection of areas that are suspicious for cancer as an adjunct (supplement) to the review of digitally-scanned slide images from prostate biopsies (tissue removed from the body). The software, called Paige Prostate, is the first artificial intelligence (AI)-based software designed to identify an area of interest on the prostate biopsy image with the highest likelihood of harboring cancer so it can be reviewed further by the pathologist if the area of concern has not been identified on initial review.

REGULATORY FDA

#ai/software

View Analyst & Ambassador Comments
Go to original news
Sep 13,2021

Almost Two Thirds of Thoracic Oncologists Used Telehealth for the First-Time During Pandemic: IASLC Survey

Nearly two-thirds of thoracic oncologists surveyed indicated they used telehealth tools for the first time during the COVID-19 pandemic, according to a report issued at the IASLC 2021 World Conference on Lung Cancer.

#telehealth

View Analyst & Ambassador Comments
Go to original news
Sep 27,2021

AI Tool Improves Accuracy of Breast Cancer Imaging

A computer program trained to see patterns among thousands of breast ultrasound images can aid physicians in accurately diagnosing breast cancer, a new study shows. When tested separately on 44,755 already completed ultrasound exams, the artificial intelligence (AI) tool improved radiologists' ability to correctly identify the disease by 37 percent and reduced the number of tissue samples, or biopsies, needed to confirm suspect tumors by 27 percent.

CLINICAL STUDY

#ai/software

View Analyst & Ambassador Comments
Go to original news
Sep 17,2021

Roche Opens Access to Pathology Imaging Tools to Improve Patient Care

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the introduction of the Roche Digital Pathology Open Environment that allows software developers to easily integrate their image analysis tools for tumour tissue with Roche's uPath enterprise software, an application for pathologist workflow. This open environment allows for the secure exchange and flow of data so that pathologists can access advanced algorithms from third parties alongside Roche's menu of artificial intelligence-based image analysis tools.

PRODUCT

#ai/software

#platform

View Analyst & Ambassador Comments
Go to original news
Sep 02,2021

Artificial Intelligence In Healthcare: 10 Medical Fields A.I. Will Change Completely

IBM Watson launched its dedicated program for oncologists, providing clinicians with evidence-based treatment options. Watson for Oncology has an advanced ability to analyse the meaning and context of structured and unstructured data in clinical notes and reports that may be critical to selecting a treatment pathway. By combining attributes from the patient’s file with clinical expertise, external research, and data, the program identifies potential treatment plans for a patient. Know more about IBM’s Moonshot Ambition In Healthcare in the article.

PRODUCT

#platform

#ai/software

View Analyst & Ambassador Comments
Go to original news
Sep 14,2021

The Future of Digital Therapeutics: Prescribing Apps Or Sensors A Reality?

Digital therapeutics are not at a conceptual stage but are well within the production and delivery stages. In fact, DTx targeting chronic medical and mental conditions have been developed over the past 15 to 20 years. The Digital Therapeutics Alliance even has a product library of DTx. An example of DTx is Kaiku Health. The app supports cancer patients by allowing them to report potential symptoms that they might encounter; subsequently, it shares self-care instructions with them.

PRODUCT

#dtx

View Analyst & Ambassador Comments
Go to original news
Sep 22,2021

The Blue Box is betting on the future of at-home breast cancer tests

You can take a pregnancy test or colon cancer test from your bathroom, or, these days, a COVID-19 test from the comfort of your living room. You might one day be able to get a breast cancer screening at home, too, if you have a urine sample and an artificial nose. That’s the vision behind The Blue Box, a startup competing this week at TechCrunch Disrupt’s Startup Battlefield.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Subscribe to ONCOLOGY